Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes
eLife · 24.10.2023 · 12
DOI: 10.7554/elife.87255 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 24.10.2023. Verfasst von Xiang Wang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Denali Therapeutics, South San Francisco, United States. Hauptthemen laut MEDLINE: Biological Phenomena, Lysosomes, rab GTP-Binding Proteins. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Leucine-rich repeat kinase 2 (LRRK2) variants associated with Parkinson’s disease (PD) and Crohn’s disease lead to increased phosphorylation of its Rab substrates. While it has been recently shown that perturbations in cellular homeostasis including lysosomal damage can increase LRRK2 activity and localization to lysosomes, the molecular mechanisms by which LRRK2 activity is regulated have remained poorly defined. We performed a targeted siRNA screen to identify regulators of LRRK2 activity and identified Rab12 as a novel modulator of LRRK2-dependent phosphorylation of one of its substrates, Rab10. Using a combination of imaging and immunopurification methods to isolate lysosomes, we demonstrated that Rab12 is actively recruited to damaged lysosomes and leads to a local and LRRK2-dependent increase in Rab10 phosphorylation. PD-linked variants, including LRRK2 R1441G and VPS35 D620N, lead to increased recruitment of LRRK2 to the lysosome and a local elevation in lysosomal levels of pT73 Rab10. Together, these data suggest a conserved mechanism by which Rab12, in response to damage or expression of PD-associated variants, facilitates the recruitment of LRRK2 and phosphorylation of its Rab substrate(s) at the lysosome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Denali Therapeutics, South San Francisco, United States.
- Department of Pharmaceutics, University of Minnesota, Minneapolis, United States.
ORCID-Profile: Xiang Wang, Oliver B Davis, David Joy, Joseph W Lewcock, Anastasia G Henry
Zitieren
APA
Wang, X., Bondar, V. V., Davis, O. B., Maloney, M. T., Agam, M., Chin, M. Y., Cheuk-Nga Ho, A., Ghosh, R., Leto, D. E., Joy, D., Calvert, M. E. K., Lewcock, J. W., Di Paolo, G., Thorne, R. G., Sweeney, Z. K., & Henry, A. G. (2023). Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. eLife, 12. https://doi.org/10.7554/elife.87255
Vancouver
Wang X, Bondar VV, Davis OB, Maloney MT, Agam M, Chin MY, et al. Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes. eLife. 2023;12. doi:10.7554/elife.87255
BibTeX
@article{Wang2023,
author = {Wang, Xiang and Bondar, Vitaliy V and Davis, Oliver B and Maloney, Michael T and Agam, Maayan and Chin, Marcus Y and Cheuk-Nga Ho, Audrey and Ghosh, Rajarshi and Leto, Dara E and Joy, David and Calvert, Meredith E K and Lewcock, Joseph W and Di Paolo, Gilbert and Thorne, Robert G and Sweeney, Zachary K and Henry, Anastasia G},
title = {Rab12 is a regulator of LRRK2 and its activation by damaged lysosomes},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.87255}
}
EUVIMED